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          Twist1   and the closely related   twist2   (also 
known as   dermo1  ) genes encode basic helix-
loop-helix transcription factors involved in the 
formation of mesoderm in   Drosophila melano-
gaster   (  1  ), cranial neural tube and limb morpho-
genesis in mice (  2  ), metastasis of tumor cells (  3  ), 
control of apoptosis, and expression of cyto-
kine genes in infl  ammation (  4, 5  ). Mice defi  -
cient for   twist2   or haploinsuffi   cient for both 
  twist1   and   twist2   succumb to severe systemic 
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  The basic helix-loop-helix transcriptional repressor   twist1  , as an antagonist of nuclear 
factor     B (NF-    B)  –  dependent cytokine expression, is involved in the regulation of infl  am-
mation-induced immunopathology. We show that   twist1   is expressed by activated T helper 
(Th) 1 effector memory (EM) cells. Induction of   twist1   in Th cells depended on NF-    B, 
nuclear factor of activated T cells (NFAT), and interleukin (IL)-12 signaling via signal 
transducer and activator of transcription (STAT) 4. Expression of   twist1   was transient after 
T cell receptor engagement, and increased upon repeated stimulation of Th1 cells. Imprint-
ing for enhanced   twist1   expression was characteristic of repeatedly restimulated EM Th 
cells, and thus of the pathogenic memory Th cells characteristic of chronic infl  ammation. 
Th lymphocytes from the infl  amed joint or gut tissue of patients with rheumatic diseases, 
Crohn  ’  s disease or ulcerative colitis expressed high levels of   twist1  . Expression of   twist1   in 
Th1 lymphocytes limited the expression of the cytokines interferon-    , IL-2, and tumor 
necrosis factor-    , and ameliorated Th1-mediated immunopathology in delayed-type hyper-
sensitivity and antigen-induced arthritis. 
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T lymphocytes expressing the transgenic DO11.10 TCR 
specifi  c for OVA were activated in vitro with splenic APCs 
and the cognate peptide OVA  327-339   under conditions that 
induce functional diff   erentiation into Th1 cells, i.e., addi-
tion of IL-12 and blocking antibodies specifi  c for IL-4. The 
transcriptional profi   les of once- and four-time  –  stimulated 
Th1 cells were compared using high-density DNA microar-
rays. Among the 17 genes diff  erentially expressed by a factor 
of two or more was   twist1  . Expression of   twist1   was up-regu-
lated 38-fold in four-time  –   versus once-stimulated Th1 cells 
(Table S1, available at http://www.jem.org/cgi/content/full/
jem.20072468/DC1). 
    Twist1   expression in Th1, but not Th2 or Th17, cells was 
confi  rmed by real-time PCR (  Fig. 1  ).     Twist1   mRNA expres-
sion in resting Th1 cells correlated with their age in vitro and 
the number of restimulations they had experienced. Expres-
sion was further enhanced 3 h after polyclonal stimulation ei-
ther with PMA and the Ca  2+   ionophore ionomycin, or with 
CD3- and CD28-specifi  c antibodies (  Fig. 1 A  ). When deter-
mined 3 h after restimulation with anti-CD3/-CD28 anti-
bodies, expression of   twist1   was close to the detection limit in 
naive Th cells. Expression increased     15-fold during the fi  rst 
Th1-polarizing stimulation, another 10-fold during the sec-
ond stimulation, and another 3-fold during the third stimula-
tion, reaching the maximum level after the fourth stimulation 
and remaining stable thereafter (  Fig. 1 A  ). With PMA/iono-
mycin restimulation, maximum levels of   twist1   mRNA were 
reached after two rounds of stimulation. In Th1 cells, upon 
anti-CD3/-CD28 restimulation,   twist1   mRNA expression was 
up-regulated within the fi  rst hour, reaching maximum levels 
after 3 h, and decreasing again thereafter (  Fig. 1 B  ). Expression 
of   twist1   mRNA was also detectable in restimulated Th2 cells, 
but its level remained 30-fold lower than in Th1 cells. In Th17 
cells, the level of   twist1   mRNA expression was even lower than 
in Th2 cells (  Fig. 1 C  ). 
  Twist1 protein was detectable in 6-d-old restimulated 
Th1 cells. In 24-d-old Th1 cells, expression was enhanced. 
In resting Th1 cells and in reactivated or resting Th2 cells, 
Twist1 was not detectable by immunoblotting (  Fig. 1 D  ). In 
agreement with the expression of   twist1   mRNA, Twist1 pro-
tein expression peaked 3 h after reactivation, and then ceased, 
with levels still detectable 48 h after restimulation (  Fig. 1 E  ), 
but not at 6 d after restimulation. 
    Twist2   was not expressed in the Th1 and Th2 cells analyzed 
here, as determined by real-time PCR (unpublished data). 
  Control of   twist1   expression in Th1 lymphocytes 
  The specifi  c expression of   twist1   by activated Th1 cells sug-
gests that Th1-polarizing or Th1-specifi  c signals are required for 
the induction of   twist1   expression in Th cells. Indeed, IL-12/
STAT4 signaling induced   twist1   expression in a dose-dependent 
fashion ( Fig. 2 A ).   IFN-    and STAT1 signaling did not induce 
  twist1   expression in the absence of IL-12 (  Fig. 2 A  ). T-bet, a 
T box transcription factor suffi   cient to induce Th1 diff  erentia-
tion (  19  ), is not required for induction of expression of   twist1  ; 
induction   of twist1   by IL-12 was comparable in T-bet  –  defi  cient 
infl  ammation, demonstrating the central role of Twist pro-
teins in the regulation of infl  ammation.   Twist1   and   twist2   are 
expressed by fi  broblasts and macrophages, and expression is 
promoted by TNF-     and type I IFNs (  4, 5  ). The involve-
ment of Twist expression by fi  broblasts and macrophages in 
the control of infl  ammation is probable, but has not been in-
vestigated in detail so far. 
  T helper 1 (Th1) lymphocytes are potent inducers of in-
fl  ammation. This has been demonstrated by adoptive transfer 
of Th1 lymphocytes in murine models of Th1-associated in-
fl  ammatory diseases such as diabetes (  6  ), infl  ammatory bowel 
disease (  7  ), and rheumatoid arthritis (  8  ). In these models, the 
induction of infl  ammation in a particular tissue by Th1 lym-
phocytes is dependent on restimulation by the cognate anti-
gen in that tissue. Induction of infl  ammation by Th1 cells is 
mediated by expression of the proinfl  ammatory  cytokines 
TNF-     and IFN-    , the latter being a hallmark of Th1 diff  er-
entiation. IFN-     also induces expression of the chemokine 
receptor CXCR3 and its ligands CXCL9, -10, and -11, at-
tracting Th1 cells specifi  cally to infl  amed tissue (  9  ). Th cells 
with the capacity to recall IFN-     expression, i.e., Th1 mem-
ory cells, are detectable in chronically infl  amed tissue (  10, 11  ). 
The role of Th1 cells in the development and maintenance of 
chronic infl  ammation is less clear. Anti  –  IFN-     therapy has 
been shown to be benefi  cial in various Th1-associated in-
fl  ammatory diseases (  12, 13  ). However, a regulatory role for 
IFN-     has also been demonstrated, based on the induction of 
inducible nitric oxide synthase (  14  ) and of IL-12 in antigen-
presenting cells, in turn increasing the IL-10 synthesis of Th1 
cells (  15  ). Furthermore, IFN-     inhibits the diff  erentiation of 
naive Th cells into proinfl  ammatory Th17 cells (  16, 17  ). 
  In this study, we demonstrate specifi  c autoregulation of 
Th1 cells by the transcription factor   twist1  . Expression of 
  twist1   in Th cells is induced by IL-12/STAT4, NF-    B, and 
NFAT, and thus is specifi  c for Th1 cells. Th1 eff  ector mem-
ory (EM) cells (  18  ) show increased transient reexpression of 
  twist1   upon T cell receptor engagement.   Twist1   reduces the 
functionality of Th1 cells by attenuating expression of IL-2, 
TNF-    , and IFN-    . Th cells isolated from chronically in-
fl  amed gut tissue of patients with ulcerative colitis (UC) or 
Crohn  ’  s disease (CD) and synovial fl  uid of patients with spon-
dyloarthropathies or rheumatoid arthritis are imprinted to 
express high levels of   twist1  , which indicates a history of re-
peated restimulation and an involvement in the pathogenesis 
of the disease. In murine models of acute and chronic infl  am-
mation, i.e., delayed-type hypersensitivity (DTH) and antigen-
induced arthritis, expression of   twist1   by Th1 cells regulates 
Th1-mediated infl  ammation. 
    RESULTS   
    Twist1   is transiently expressed in repeatedly activated 
Th1 cells 
  To defi  ne transcriptional changes during Th1 memory cell 
diff  erentiation, we compared the global gene expression 
of murine Th1 cells, which were activated with antigen 
once or repeatedly at 6-d intervals. Naive CD4  +  CD62L  hi   JEM VOL. 205, August 4, 2008 
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mouse revealed a conserved STAT binding site at position 
    117 to     137 (  Fig. 3 A  ).   STAT4 did bind to the proxi-
mal promoter of   twist1   in activated Th1 cells in the pres-
ence of IL-12 as shown by chromatin immunoprecipitation 
(ChIP;   Fig. 2 D  ). 
and wild-type Th cells (  Fig. 2 B  ). Also, ectopically expressed 
T-bet did not induce   twist1   expression in the absence of IL-12 
in activated Th cells (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20072468/DC1). 
  When CD4  +   T lymphocytes of STAT4-defi  cient mice were 
stimulated in the presence of IL-12 and IFN-    , no induction 
of   twist1   expression was detectable (  Fig. 2 C  ). Phylogenetic 
comparison of the proximal promoter of   twist1   from man and 
    Figure 1.       Twist1   expression is induced in Th1, but not Th2 or Th17 
cells.   CD4 + CD62L hi   OVA-specifi  c T lymphocytes were stimulated in vitro 
under Th1 or Th2, or under Th17-polarizing conditions. Functional polar-
ization of Th1, Th2, and Th17 cells, i.e., the cytokine expression profi  le, was 
confi  rmed by intracellular immunofl  uorescence (Fig. S1). (A)   Twist1   mRNA 
in resting cells 6 d after the last stimulation (Th1; circles) or after 3 h of 
restimulation with anti-CD3/CD28 and IL-2 (Th1; squares) or PMA/iono-
mycin and IL-2 (Th1; triangles: Th2; diamonds) was determined by RT-PCR 
and normalized to hypoxanthine guanine phosphoribosyl transferase 
(HPRT). (B) Kinetics of   twist1   mRNA expression in 6-d-old (open bars) and 
24-d-old (shaded bars) Th1 cells, after stimulation with anti-CD3/CD28 
and IL-2 or IL-2 alone. (C)   Twist1   transcript levels in 6-d-old Th1, Th2, and 
Th17 cells after reactivation with PMA/ionomycin. (D) Twist1 protein ex-
pression in resting (-) and 5 h PMA/ionomycin-restimulated (+) 6- and 
24-d-old Th1 and Th2 cells. Control:     -Tubulin immunoblot (bottom). 
(E) Kinetics of Twist1 protein expression in 24-d-old Th1 cells, before and 
at the indicated time intervals of stimulation with anti-CD3/CD28 and 
IL-2. Data are representative of two experiments. Fig. S1 is available at 
http://www.jem.org/cgi/content/full/jem.20072468/DC1.   
    Figure 2.       Twist1   induction requires IL-12 signaling via STAT4, but 
not IFN-     or T-bet.  (A)  CD62L hi   DO11.10 Th cells were stimulated for 5 d 
under Th1-polarizing conditions (5 ng/ml IL-12, anti-IL4), reduced IL-12 
(1/25:200 pg/ml; 1/625:8 pg/ml, anti-IL4), in the absence of IL-12 (anti  –
  IL-12, anti-IL4), in the presence of IFN-     (10 ng/ml IFN-   ,  anti-IL-12, 
anti-IL-4), or under Th2-polarizing conditions.   Twist1   mRNA in Th cells 
activated for 3 h with PMA/ionomycin and IL-2 was quantifi  ed by RT-PCR. 
The amount of   twist1   transcripts induced under Th1-polarizing conditions 
was set to 1. Data are presented as the mean   ±   the SD of at least three 
experiments. (B) CD62L  hi   Th cells of T-bet     /     mice and syngenic BALB/c 
mice were stimulated with anti-CD3/CD28 and BALB/c APCs under Th1 
(IL-12 and IFN-    ), or under Th2-polarizing conditions for 6 d. Data repre-
sent the mean   ±   the SD of three experiments. The amount of   twist1   tran-
scripts induced in activated wt Th1 cells was set to 1. (C) CD4  +   cells  of 
STAT4     /     and syngenic BALB/c mice were stimulated with anti-CD3/CD28, 
and BALB/c APCs under Th1 (IL-12 and IFN-    ) or under Th2-polarizing 
conditions for 5 d. Data represent the mean   ±   SD (four mice each). (D) The 
binding of STAT4 to the proximal promoter of   twist1   was analyzed by 
ChIP. 6-d-old Th1 cells were restimulated with PMA/ionomycin in the 
presence of 10 ng/ml IL-12 for 3 h or left unstimulated. The immuno-
precipitated DNA was quantifi  ed by RT-PCR using primers specifi  c for the 
proximal   twist1   promoter. The precipitated DNA was normalized to the 
amount of input DNA. The amount of   twist1   transcripts precipitated in 
the presence of IL-12 was set to 1. Data represent the mean   ±   SD of three 
experiments. (E) Naive DO11.10 Th cells were stimulated for 5 d with APCs 
and OVA  327-339   under Th1-polarizing conditions. Cells were restimulated 
under the same conditions (Th1), or in the presence of anti  –  IL-12.   Twist1  
transcripts were quantifi  ed on d 11. The amount of   twist1   mRNA on d 5 
was set to 1. Data represent mean   ±   SD of three experiments.     1892 TWIST1 CONTROLS TH1-MEDIATED IMMUNITY   | Niesner et al. 
.org/cgi/content/full/jem.20072468/DC1), but also did not 
induce   twist1   expression in activated Th2 cells, as described 
in   Fig. 1  . 
  IL-12/STAT4 is required for the initial induction of 
  twist1   expression and apparently imprints Th1 cells for 
reexpression of   twist1   upon reactivation by antigen only. 
Upon restimulation of Th1 cells, cells cultured in the ab-
sence of IL-12 showed a 12-fold increase in the expression 
of   twist1  , as compared with a 16-fold increase in the pres-
ence of IL-12 (  Fig. 2 E  ). IL-4/STAT6 signaling could not 
suppress   twist1   expression in residual IFN-      –  expressing 
cells of Th2 cultures (Fig. S3, available at http://www.jem
    Figure 3.         Signaling through NFAT and NF-    B is required for in-
duction of   twist1   expression.   (A) Comparison of the genomic sequence 
of the murine and the human proximal   twist1   promoter  (   150 to    100). 
The murine sequence is displayed with conserved bases in capital letters. 
Selected putative DNA-binding motifs are indicated. ISRE, IFN-stimulated 
response element. (B)   Twist1   mRNA in 24-d-old Th1 cells restimulated for 
3 h with PMA/ionomycin and IL-2 in the presence of serial dilutions of the 
NF-    B inhibitor pyrrolidine dithiocarbamate (PDTC; circles; starting con-
centration 50   μ  M), the NFAT inhibitor BTP1 (squares; starting concentra-
tion 100 nM), or the NF-    B and NFAT inhibitor cyclosporine A (CsA; 
triangles; starting concentration 30 nM). (C) 24-d-old Th1 cells were re-
stimulated in the presence of IL-2 for 3 h with IL-2 alone (unstimulated) 
or 10 ng/ml TNF-    , PMA, or PMA/ionomycin. The binding of NFAT1 
(D) and the NF-    B subunit p65 (E) to the proximal promoter of   twist1   was 
analyzed by ChIP. 18  –  24-d-old Th1 and Th2 cells either in the resting 
state (-) or after restimulation with PMA/ionomycin and IL-2 for 1 h (+) 
were used. The immunoprecipitated DNA was quantifi  ed by RT-PCR using 
primers specifi  c for the proximal promoter. The precipitated DNA was 
normalized to the amount of input DNA. The amount of   twist1   transcripts 
precipitated in activated Th1 cells was set to 1. Data represent mean   ±   SD 
of 3 experiments.     
    Figure 4.         Ex vivo isolated memory Th cells express   twist1  .   Cells 
were sorted by fl  ow cytometry and restimulated for 3 h with PMA/iono-
mycin (A  –  C). (A) Cells were isolated from the spleen and lymph nodes of 
8  –  12-wk-old DO11.10 mice (squares, each representing a pool of 15 indi-
vidual mice) and the pooled inguinal and mesenteric lymph nodes of 4  –  6-
mo-old nephritic MRL/  lpr   mice (circles, 1  –  2 mice each). Of note: 90% of 
the CD4  + CD62L hi   cells in MRL/  lpr   mice represented activated (CD44  + ) 
cells (not depicted). (B)   Twist1   mRNA in peripheral human Th lympho-
cytes. The mean expression of   twist1   mRNA normalized to ubiquitin 
ligase H5 in total CD3  + CD4 +   cells was set to 1. Subpopulations were de-
fi  ned according to expression of the following surface markers: naive 
(CD4  + CD45RA + CCR7 +  ), CM (CD4  + CD45RA - CCR7 +  ), EM (CD4  + CD45RA -
 CCR7 -  ) with each data point representing one individual healthy donor. 
(C)   Twist1   transcripts in CD3  + CD4 +   cells  purifi  ed from patient material: 
blood (total peripheral CD3  + CD4 +   cells from healthy donors, see B), colon 
(noninfl  amed colon tissue), UC, and CD (endoscopic biopsies from UC and 
CD patients, respectively), RA, ReA, PsA, and AS (synovial fl  uid from rheu-
matoid arthritis, reactive arthritis, psoriatic arthritis, and ankylosing spon-
dylitis patients, respectively) with each dot representing one individual 
patient. Mean   twist1   mRNA expression is displayed from patients who 
were repeatedly sampled.     JEM VOL. 205, August 4, 2008 
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as compared with Th2 cells (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20072468/DC1). 
  Th cell  –  specifi  c   twist1   expression in vivo 
  The exclusive expression of   twist1   in Th1 EM cells gener-
ated in vitro is refl  ected by the expression pattern of   twist1   
in Th cells isolated ex vivo. Activated CD4  +  CD62L  hi   naive 
and CD4  +  CD62L  lo   memory cells isolated from the spleen 
and lymph nodes of healthy DO11.10 mice, kept under 
specifi  c pathogen  –  free conditions, expressed low levels of 
  twist1   (  Fig. 4 A  ).   In CD4  +  CD62L  lo   memory Th cells from 
lymph nodes of 4  –  6-mo-old nephritic lupus-prone MRL/
  lpr   mice (  23  )   twist1   mRNA was up-regulated by approx-
imately twofold, as compared with CD4  +  CD62L  lo   Th cells 
from DO11.10 spleen (  Fig. 4 A  ).   Twist1   expression was 
enhanced by fi  ve- to eightfold in CD3  +  B220  +   T cells from 
MRL/  lpr   mice, which represent chronically activated T lym-
phocytes (  24, 25  ). 
  In analogy to murine Th lymphocytes, human Th cells 
can express   twist1. Twist1   expression was enhanced by three-
fold in EM (i.e., CD45RA       CCR7       ) Th cells, and eightfold 
in   “  terminally  ”   diff  erentiated CD27        EM Th cells (  26, 27  ), 
whereas naive (CD45RA  +  CCR7  +  ) and central memory (CM; 
i.e., CD45RA       CCR7  +  ) Th lymphocytes expressed less   twist1   
than unseparated Th cells. Activated Th1 EM cells, charac-
terized by the expression of CCR5 (  28  ), expressed   twist1  , 
whereas Th2 EM cells characterized by expression of chemo-
attractant receptor-homologous molecule expressed on Th2 
cells (CRTh2) (  29  ) did not (  Fig. 4 B  ). 
  Because   twist1   is expressed transiently upon activation 
of Th1 cells, we investigated whether signals from the TCR 
are involved in   twist1   expression control. Phylogenetically 
conserved binding sites for the TCR signal transducers NF-
    B and NFAT are located in the   twist1   promoter at positions 
    104 to     116 and     129 to     140 (  Fig. 3 A  ). The NF-    B 
inhibitor pyrrolidine dithiocarbamate (  20  ), the NFAT-specifi  c 
inhibitory 3,5-bistrifl  uoromethyl pyrazole derivative BTP1 (  21  ), 
and the calcineurin-inhibitor cyclosporine A (  22  ) all blocked 
the PMA/ionomycin-induced expression of   twist1   mRNA 
(  Fig. 3 B  ), showing that both NFAT and NF-    B are required 
for induction of   twist1   expression in Th1 cells. Accordingly, 
stimulation with either TNF-     or PMA alone, both activating 
NF-    B (  20  ) but not NFAT, did not induce   twist1   expression, 
whereas PMA in combination with the NFAT-activating iono-
mycin did (  Fig. 3 C  ). 
  Using ChIP, the specifi  c binding of NFAT1 and the trans-
activating NF-    B subunit p65 to the   twist1   promoter of re-
peatedly stimulated Th1 cells was evident 1 h after reactivation 
(  Fig. 3, D–E  ). In Th2 cells, no activation-induced binding 
of NFAT1 or NF-    B to the   twist1   promoter was detectable, 
emphasizing that NFAT1 and NF-    B are required, but not 
suffi   cient, to induce transcription of   twist1   in Th cells. For the 
initial expression of   twist1   in Th1 cells, and its imprinting for 
reexpression in further restimulations, the concerted action of 
activated STAT4, NFAT1, and NF-    B is required. Imprint-
ing of the   twist1   gene for reexpression in Th1 cells is refl  ected 
by increased acetylation of histone H3 and trimethylated his-
tone H3 at lysine 4, in both resting and reactivated Th1 cells, 
    Figure 5.         Genes differentially expressed upon ectopic   twist1   overexpression.   Splenic DO11.10 cells were activated in vitro with the cognate pep-
tide OVA  327-339   in the presence of 1 ng/ml IL-12 and 1 ng/ml IL-2. On d 2, cells were infected with control retrovirus, or   twist1-  encoding virus. On d 5, cells 
were sorted according to expression of the viral marker gene   gfp  . Cells were restimulated for 4 h with PMA/ionomycin. The transcriptional profi  les of 
duplicates of cultures were compared.     1894 TWIST1 CONTROLS TH1-MEDIATED IMMUNITY   | Niesner et al. 
expressed   twist1   transcript levels lower than the reference value 
of total peripheral Th cells (unpublished data). 
  Functional modulation of Th1 cells by   twist1   
  We analyzed the impact of   twist1   on the function of Th1 EM 
cells by ectopic overexpression of   twist1   in murine DO11.10 
Th cells. A global view of   twist1  -induced modulation of gene 
expression in Th1 cells is provided in   Fig. 5  .   Of the 14,000 
genes analyzed for transcription, 58 were diff  erentially expressed 
by a factor of 1.5 or more when comparing activated Th1 cells 
that express   twist1   ectopically and those that do not (  Fig. 5  ). 
These genes fall into 4 groups, with respect to their presump-
tive function: 17 genes are involved in cell activation and apop-
tosis, 11 genes are involved in cell adhesion and motility, 13 
genes relate to the chemokine/cytokine repertoire of Th1 cells, 
and 17 genes are of metabolic or undefi  ned relevance. 
  Of relevance for the eff  ector function of Th1 EM cells,  twist1   
attenuated expression of the eff  ector cytokine genes   il-2, ifn-      , 
and   tnf-       by a factor of up to 1.6 (  Fig. 5   and Table S3, available 
at http://www.jem.org/cgi/content/full/jem.20072468/DC1).   
The moderate reduction of mRNA levels of eff  ector cyto-
kines had a drastic eff  ect on protein expression regardless of the 
direction of Th cell diff  erentiation. Ectopic   twist1   expression 
reduced the frequencies of cytokine-expressing reactivated 
Th1 or Th2, or of Th cells that had been stimulated without 
addition of polarizing cytokines to the culture, to 40  –  50% of 
the controls (  Fig. 6   and Fig. S5). 
  The molecular basis of the regulation of cytokine gene 
expression by   twist1   could be either direct inhibition of 
NF-    B, as has been shown for COS cells (  4  ), or binding of 
Twist1 to E-boxes of regulatory elements of the cytokine 
genes, blocking activating transcription factors, as has been 
shown for primary macrophages (  5  ). Here, we show that ec-
topic   twist1   expression in activated Th cells cannot inhibit 
activation-induced transcription of an NF-    B  –  reporter con-
struct lacking E-boxes, i.e., Twist1 does not inhibit NF-    B 
directly (  Fig. 7 A  ), in contrast to the constitutively active mu-
tant form of   inhibitor of NF-    B   (  I-    B    M  ), in an experimental 
situation where both Twist1 and I-    B    M are expressed at 
similar levels (Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20072468/DC1), and both attenuate the 
expression of endogenous cytokine genes to the same degree 
(  Fig. 7 B  ).   This result implies that   twist1   regulates gene ex-
pression of Th1 cells by binding to E-boxes of specifi  c target 
genes, and not the entirety of NF-    B  –  regulated genes. NF-    B 
signaling for the generation and survival of Th1 memory 
cells (  30, 31  ) is not inhibited by   twist1  , as is also evident from 
the high   twist1   expression of repeatedly restimulated Th1 
cells (  Fig. 1  ). 
    Twist1   regulates Th1-mediated infl  ammation 
  In a murine transfer model of OVA-specifi  c DTH, the eff  ect 
of   twist1   expression on the infl  ammation induced by trans-
ferred Th1 cells was analyzed. OVA-specifi  c 6-d-old Th1 
cells ectopically overexpressing   twist1   and control Th1 cells 
were transferred intravenously into naive BALB/c mice. 
  Th cells isolated from infl  amed tissue of patients with 
chronic infl  ammatory diseases are imprinted for high   twist1   
expression. Although highly variable,   twist1   transcripts were 
increased by up to 400-fold, as compared with peripheral Th 
cells, in CD3  +  CD4  +   cells isolated from the synovial fl  uid of in-
fl  amed joints of patients with rheumatoid arthritis or spondylo-
arthropathies, and in Th cells isolated from mucosal endoscopic 
biopsies and surgical specimens of patients suff  ering from CD 
or UC (  Fig. 4 C   and Table S2, available at http://www.jem
.org/cgi/content/full/jem.20072468/DC1).  Twist1   mRNA 
expression in repeatedly sampled patients with persistent in-
fl  ammation of colon or synovia remained in the same range 
over up to 18 mo (Table S2). Among T cells isolated from the 
infl  amed tissue, only CD4  +   Th cells showed enhanced   twist1   
expression. CD3  +  CD4        cells, i.e., cytotoxic (Tc) lymphocytes, 
    Figure 6.       Twist1   suppresses the expression of effector cytokines.  
DO11.10 Th cells were stimulated for 5 d under Th1- or Th2-polarizing 
conditions or without addition of cytokines. On d 2, cells were infected 
with control virus or   twist1  -encoding virus. The cells were restimulated 
on d 6 and stained for intracellular cytokine expression. (A) Representative 
histograms of cytokine expression in Th cells ectopically expressing   twist1  
(black line) and control cells (gray fi  lled). The cells displayed were gated 
for expression of CD4 and the viral marker gene   gfp  . (B) Frequencies of 
cytokine-expressing cells among infected, i.e., GFP  + CD4 +   T cells relative to 
the noninfected CD4  +   cells. Cells had been stimulated without addition 
of cytokines and infected with control virus (open bars) or   twist1 -encod-
ing virus (fi  lled bars). Data represent the mean   ±   SD of four indepen-
dent experiments.   JEM VOL. 205, August 4, 2008 
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ized OVA into the knee joint, and histological analysis was 
performed 3 wk after induction of arthritis, i.e., in the chronic 
phase of infl  ammation.   Twist1   knockdown and control Th1 
cells equally homed to and persisted in the spleen and mesen-
teric and draining lymph nodes (  Fig. 9, C  –  E  ). However,   twist1   
knockdown in Th1 cells resulted in a signifi  cantly higher his-
tological score of infl  ammation and tissue destruction (  Fig. 9 F   
and Table S4, available at http://www.jem.org/cgi/content/
full/jem.20072468/DC1). In particular, infi  ltration of granu-
locytes and mononuclear cells into the infl  amed tissue of the 
knee joint was drastically enhanced (  Fig. 10   and Fig. S8), as 
were characteristics of chronic infl  ammation, i.e., prominent 
hyperplasia of the lining cells, pannus formation, increased 
vascularization, and hyperplasia of synovial fi  broblasts in the 
sublining layer (  Fig. 10   and Fig. S8).   Increased numbers of 
Gr-1  +   granulocytes at the surface of the synovium and focal 
accumulation of F4/80  +   macrophages were observed after 
transfer of   twist1   knockdown Th1 cells as compared with con-
trol Th1 cells (Fig. S8). Anti-TNF-     staining of joint sections 
revealed stronger TNF-     expression, especially in the lining 
cells and the sublining layer after transfer of Th1 cells express-
ing a   twist1  -targeting shRNA (  Fig. 10  ). Presumably as an ad-
ditional consequence of the higher infl  ammation in the mice 
receiving   twist1   knockdown Th1 cells, more CD3  +   T cells 
were found in the infl  amed joints (  Fig. 10  ). 
    DISCUSSION   
  Control of infl  ammation critically depends on the   twist   genes. 
Genetic haploinsuffi   ciency of both   twist1   and   twist2   results in 
fatal systemic infl  ammatory immunopathology in mice, which 
die before day 14 (  4  ). In this study, we show that   twist1   is ex-
pressed in Th1 EM cells. Its expression is induced by IL-12 
After 1 d, OVA  323-339   emulsifi  ed in IFA was injected into one 
footpad and the swelling of this footpad was monitored. Th1 
cells overexpressing   twist1   showed a signifi  cantly (P   <   0.05) 
reduced induction of footpad swelling, starting from day 4 to 
7, when compared with control Th1 cells (  Fig. 8 A  ).   For 
DTH mediated by Th1 cells the proinfl  ammatory role of 
Th1-derived cytokines such as IFN-     has been shown (  32  ). 
Transferred Th cells overexpressing   twist1  , when reisolated 
from the draining lymph nodes of the host, expressed four-
fold reduced levels of IFN-     mRNA as compared with the 
control cells (  Fig. 8 B  ). Homing of transferred Th1 cell pop-
ulations to the infl  amed tissue and the draining lymph nodes 
was not aff  ected by   twist1   overexpression, as shown by the 
transfer of radiolabeled cells (  Fig. 8 C  ). The accumulation of 
ectopically   twist1-  expressing Th1 cells in the draining lymph 
nodes and the infl  amed foot pads, as well as in other organs 
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20072468/DC1), was comparable to that of transferred 
control Th1 cells. 
  Autoregulation of Th1-mediated infl  ammation by   twist1   
was also analyzed in a murine adoptive transfer model of antigen-
induced arthritis (  Fig. 9 A  ).   In this model, we used the com-
plementary genetic approach to knockdown   twist1   expression 
in Th1 cells by RNA interference. Murine DO11.10 Th1 
cells generated in vitro were infected with a retrovirus encod-
ing a small hairpin RNA (shRNA) targeting   twist1   (  3  ) or a 
corresponding scrambled control shRNA.   Twist1  -specifi  c 
shRNA reduced the level of activation-induced endogenous 
  twist1   transcripts in Th1 cells to     30% of the control value 
(  Fig. 9 B  ). Two-time restimulated Th1 cells expressing those 
shRNAs were intravenously injected into SCID mice. 1 d af-
ter cell transfer, arthritis was induced by injection of cation-
    Figure 7.         Inhibition of NF-    B    –    mediated signaling by   twist1   is promoter-specifi  c.   DO11.10 Th cells were stimulated with OVA  327-339  , APCs, and 
1 ng/ml IL-12. On d 2, cells were infected with control virus,   twist1,   or  I-  B   M-encoding virus. On d 3, cells were nucleoporated with a mixture of a plas-
mid encoding   Renilla luciferase  , and a   fi  refl  y luciferase   reporter construct, driven by a NF-   B – responsive  promoter  (4x   B-luc). (A) Cells were restimulated 
with PMA/ionomycin for 6 h, sorted according to expression of the viral marker gene   gfp  , and luciferase signals were quantifi  ed in duplicates (mean   ±   
SD). (B) The very same Th1 cultures were restimulated on d 5 and stained for intracellular cytokine expression. Frequencies of cytokine-expressing cells 
among infected, i.e., GFP  + CD4 +   T cells, are displayed. Data are representative of two experiments.     1896 TWIST1 CONTROLS TH1-MEDIATED IMMUNITY   | Niesner et al. 
only in the original stimulation, to imprint the gene for reex-
pression. This imprinting is evident from the increased re-
expression upon stimulation with TCR signals alone, in the 
absence of IL-12, and it is refl  ected in the acetylation and tri-
methylation of H3 histones at the   twist1   promoter region, as 
is shown here. The requirement of NFAT for induction of 
  twist1   expression in Th1 cells distinguishes control of   twist1   
expression in Th cells from its control in fi  broblasts, where 
TNF-      –  induced activation of NF-    B is suffi   cient to induce 
expression (  4  ). In activated macrophages, type I IFNs induce 
the expression of   twist1   (  5  ), and they express both   twist   genes, 
i.e.,   twist1   and   twist2  , whereas activated Th1 cells exclu-
sively express   twist1.   In Th lymphocytes,   twist1   expression is 
not induced by type I IFNs. Addition of IFN-     during the 
primary activation of Th cells in the absence of IL-12 did 
not suffi   ce to induce   twist1   expression (Fig. S9, available at 
http://www.jem.org/cgi/content/full/jem.20072468/DC1). 
via STAT4 and TCR signaling, activating NFAT and NF-    B. 
Expression of   twist1   follows TCR stimulation transiently 
and increases upon repeated stimulation. Thus, imprinting 
for enhanced   twist1   expression is a hallmark of repeatedly re-
stimulated Th1 memory cells. 
  The proximal promoter of   twist1   contains phylogeneti-
cally conserved binding sites for NFAT, NF-    B, and STAT 
proteins. Both NFAT and NF-    B have to bind to the pro-
moter of   twist1   in Th cells to induce expression, i.e.,   twist1   is 
expressed only by activated Th cells. In the initial activation 
of naive Th cells, NFAT and NF-    B cannot induce tran-
scription of   twist1   on their own, but require concerted bind-
ing of activated STAT4 to the promoter of   twist1  . Of all 
costimulatory signals involved in the lineage diff  erentiation 
of murine Th1, Th2, or Th17 cells, only IL-12 was able to 
induce transcription of   twist1  . Neither IL-4, in Th2 polarization, 
nor IL-6, TGF-    , and IL-23 in Th17 polarization, could in-
duce expression of   twist1  . Of the Th1-polarizing signals, IL-
12/STAT4, but not IFN-    /STAT1, is required to induce 
  twist1   expression. T-bet is not involved. STAT4 is required 
    Figure 8.         Ectopic   twist1   overexpression controls DTH.   (A)  Naive 
DO11.10 Th cells were stimulated under Th1-polarizing conditions. On d 2, 
cells were infected with control virus (circles) or   twist1 -encoding  virus 
(squares). On d 6, infected GFP  +   cells were injected i.v. into BALB/c mice. 
The DTH response was induced by s.c. OVA  323-339  /IFA injection into the left 
footpad (fi  lled symbols), and      footpad thickness (mean   ±   SD;   n   =  4, 
Mann-Whitney test, nonparametric) was determined thereafter. Injection 
of PBS/IFA served as control (open symbols). (B) Ex vivo IFN-     mRNA  ex-
pression in transferred GFP  +   Th1 cells 24 h after DTH induction isolated 
from the draining popliteal lymph node (left foot). (C) To monitor the 
migratory capacity of the transferred cell populations, infected GFP  +   Th 
cells were radiolabeled and injected i.v. into BALB/c mice 1 d after induc-
tion of the DTH response. 24 h later radioactivity recovered from indicated 
tissues was determined using a    -counter  (mean   ±   SD;   n   =  4).   
    Figure 9.       Twist1   knockdown increases infl  ammatory response in 
murine arthritis.   (A) Experimental scheme. (B)   Twist1   mRNA in 18-d-old 
Th1 expressing   twist1  -targeting shRNA or control shRNA restimulated 
with PMA/ionomycin. (C  –  E) Cell numbers of adoptively transferred GFP  +  
Th cells in spleen, mesenteric lymph nodes, and draining lymph nodes 
were analyzed on d 21 using FlowCount Beads. (F) Transfer of Th1 cells 
expressing a   twist1  -targeting shRNA leads to a signifi  cantly higher histo-
logical score in murine arthritis compared with control Th1 cells (d 21). 
Data are representative of two experiments.     JEM VOL. 205, August 4, 2008 
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to a subset of memory cells. Among murine CD4  +  CD62L  lo   
memory-phenotype Th cells that were isolated from spleen 
or lymph nodes of naive DO11.10 mice, expression of   twist1   
is low. In CD3  +  B220  +   T cells isolated from nephritic MRL/
  lpr   mice, which represent chronically activated T cells (  24, 25  ), 
  twist1   expression is up-regulated fi  ve- to eightfold compared 
with DO11.10 memory-phenotype Th cells. This is moderate 
when compared with the     20-fold up-regulation upon re-
peated restimulation of Th1 cells observed in vitro, and may 
refl  ect the heterogeneous composition of the cell populations 
analyzed. As expected from the phylogenetic conservation of 
the   twist1   promoter,   twist1   is also expressed by activated human 
Th cells. It is low in peripheral human naive Th cells and in 
CCR7  +   CM Th cells.   Twist1   expression is enhanced in 
CCR7        EM Th cells, in particular in the   “  terminally diff  er-
entiated  ”   CCR7       CD27        EM cells (  26, 27  ). Among CCR7        
EM cells,   twist1   is expressed less by CRTh2  +   Th cells, which 
have been shown to be mostly Th2 cells ( 29  ). CCR7       CCR5  +   
EM cells, which contain Th1 EM and Th17 EM cells (  33  ) 
have up-regulated activation-induced expression of   twist1  , as 
we show here. Because at least Th17 cells generated in vitro 
do not express   twist1  , the expression in CCR7       CCR5  +   Th 
EM cells is probably caused by Th1 EM cells. Thus, the pheno-
type of human peripheral   twist1  -expressing Th cells is that of 
repeatedly restimulated Th1 EM cells. Remarkably, expression 
of   twist1   is highly up-regulated in CD3  +  CD4  +   T cells isolated 
from infl  amed tissues of patients with chronic infl  ammation 
of joints or gut. Repeated biopsies from individual patients 
show persistent   twist1   mRNA levels over time, i.e., the per-
sistence of chronically reactivated Th1 cells, despite state-of-
the-art therapeutic treatment. Their imprinting for increased 
  twist1   expression, maintained over time in individual patients, 
indicates a history of repeated restimulation and an endogenous 
regulation of proinfl  ammatory eff  ector functions under the 
control of NFAT and NF-    B. 
    Twist1   itself is a transcriptional repressor binding to E-
boxes in the regulatory regions of target genes (  34  ). For COS 
cells, it has been shown that ectopically expressed   twist1   can 
interact directly with the p65 subunit of NF-    B and inhibit 
its function (  4  ). In contrast, for primary murine macrophages, 
  twist1   has been shown to block transcription of target genes 
by binding to E-boxes within the promoter (  5  ). In this study, 
we show that in Th1 cells,   twist1   cannot block NF-    B  –  driven 
transcription of a reporter gene construct that lacks E-boxes 
in the promoter, suggesting that   twist1   acts through binding 
to E-boxes, as in macrophages. In accordance, ectopically ex-
pressed   twist1   only regulates the expression of a restricted set 
of 58 genes in 1-wk-old Th1 cells by a factor of at least 1.5. 
Expression of 29 genes is up-regulated, and that of another 
29 genes down-regulated. Apart from several genes of un-
known and metabolic function, these genes are involved in 
survival, eff  ector function, and motility of the cells. With re-
spect to cytokine expression,   twist1   reduces activation-induced 
expression of TNF-    , IL-2, and IFN-     by Th1 memory cells 
by   >  50% at the protein level. Apart from cytokine expression, 
  twist1   also decreases expression of proinfl  ammatory chemokines 
These fi  ndings provide evidence that expression of the anti-
infl  ammatory   twist   genes is controlled by type I IFNs and 
TNF-     in fi  broblasts and macrophages in innate immune re-
sponses (  4, 5  ), and is controlled by antigen and IL-12 in Th 
cells in adaptive immune responses; i.e.,   twist   expression is 
induced by those cytokines controlling the induction of in-
fl  ammatory immune responses. 
  In this study, we have identifi  ed   twist1   as a gene that is 
diff  erentially expressed by Th1 cells versus Th2 cells, com-
paring the transcriptomes of once and repeatedly restimulated 
murine Th1 and Th2 cells generated in vitro from bona fi  de 
naive Th cells. Expression of   twist1   increases upon repeated 
restimulation in vitro in Th1 cells, whereas it is not induced 
even in repeatedly restimulated Th2 or Th17 cells. Accord-
ingly, in Th cells isolated ex vivo,   twist1   expression is restricted 
    Figure 10.           Twist1   knockdown leads to pronounced signs of chronic 
infl  ammation in murine arthritis.   Representative  hematoxylin/eosin 
staining of knee joint sections (d 21) showing hyperplasia of the lining 
cells and the subintimal layer with pannus formation (bar, 200   μ  m), more 
pronounced infi  ltration of CD3  +   T cells (magnifi  cation of boxed areas in 
top row; bar, 100   μ  m) and stronger expression of TNF-     (red) especially of 
the enlarged lining and sublining layer (magnifi  cation of boxed areas in 
second row; bar, 50   μ  m) after transfer of Th1 cells expressing a   twist1 -
targeting shRNA as compared with the control group. Data are represen-
tative of fi  ve mice each.     1898 TWIST1 CONTROLS TH1-MEDIATED IMMUNITY   | Niesner et al. 
Th cells, by means of either addressing   twist1   or a gene regu-
lated by it, seems more promising, because it is more specifi  c 
for repeatedly restimulated Th1 memory cells involved in 
chronic infl  ammation. It remains to be shown whether these 
cells in chronic infl  ammatory diseases are the critical Th cells 
capable of driving infl  ammation, as we show in this study for 
the experimental model of antigen-induced arthritis. 
    MATERIALS AND METHODS   
  Mice and reagents.     MRL    lpr/lpr    , BALB/c, C57BL/6, SCID, STAT4-defi  -
cient mice (Stat4  tm1Gr  ), and OVA-TCR  tg/tg   DO11.10 mice were purchased 
from The Jackson Laboratory or were bred under specifi  c pathogen  –  free 
conditions in our animal facility. T-bet  –  defi  cient mice were a gift from 
J. Penninger (Institute for Molecular Biotechnology of the Austria Academy 
of Sciences, Vienna, Austria). All animal experiments were performed in 
accordance with institutional, state, and federal guidelines (Landesamt F  ü  r 
Gesundheit und Soziales, Berlin, Germany). Reagents were purchased from 
Sigma-Aldrich unless otherwise stated. BTP1 was synthesized by M. Paetzel 
(Humboldt University of Berlin, Berlin, Germany). Cyclosporin A was pur-
chased from Calbiochem. 
  Patients.     Endoscopic mucosal and surgical mucosal specimens were ob-
tained from UC (  n   = 9) and CD (  n   = 7) patients. UC and CD were diag-
nosed according to established clinical, endoscopic, radiological, and 
pathological criteria. All UC and CD patients displayed moderately to se-
verely active disease according to the Truelove and Witts Severity Index (  41  ) 
and the Harvey Bradshaw Severity Index (  42  ), respectively. Control samples 
were obtained from patients (  n   = 4) undergoing colonectomy because of 
colon cancer. Mucosal control specimens used in the study were from the 
macroscopically noninvolved tissue distant from any detectable lesion. Syno-
vial fl  uid was obtained from patients suff  ering from rheumatic diseases who 
had active synovitis with eff  usion. Patients with rheumatoid arthritis (RA; 
  n   = 4) fulfi  lled the American College of Rheumatology 1987 classifi  cation 
criteria for RA, patients with ankylosing spondylitis (AS;   n   = 5) fulfi  lled 
the modifi  ed New York criteria (1984), and patients with psoriatic arthritis 
(  n   = 3) or reactive arthritis (  n   = 3) fulfi  lled the European Spondyloar-
thropathy Study Group (ESSG) criteria for SpA. Clinical characteristics 
of the patients are listed in Table S2. All experiments were approved by the 
local ethics committee (Charite Ethikkommision), and all patients gave in-
formed consent. 
  Isolation of human lymphocytes.     PBMCs from buff  y coats from healthy 
donors, and synovial fl  uid mononuclear cells were isolated by density gradi-
ent centrifugation (Lymphocyte separation medium; PAA). Pooled intraepi-
thelial leukocytes and lamina propria leukocytes were obtained from mucosal 
specimens by treatment with collagenase type IV, followed by passage 
through a sieve. Mononuclear cells were collected from the 40  –  70% inter-
phase of a discontinuous percoll (Pharmacia) gradient. 
  Flow cytometry.     The following antibodies directed against murine anti-
gens were either purifi  ed from hybridoma supernatants and conjugated in-
house or purchased as indicated: anti-CD3 (145-2C11), anti-CD4 (GK1.5), 
anti-CD8 (53  –  6.7), anti-CD11c (N418), anti-CD44 (IM7), anti-CD62L 
(MEL14), anti-DO11.10 OVA-TCR (KJ1.26), anti-B220 (RA3.6B2), anti-
IL2 (JES6-5H4; Caltag Laboratories), anti-IL-4 (11B11; BD Biosciences), 
anti-IFN-     (AN18.17.24), and anti-TNF-     (MP6-XT22; Caltag). Anti-
bodies recognizing human antigens were obtained from BD Biosciences 
unless stated otherwise: anti-CD3 (OKT3; in-house conjugate), anti-CD4 
(TT1; in-house conjugate), anti-CD27 (L128), anti-CD45RA (HI100), 
anti-CRTh2 (BM16), and anti-CCR5 (2D7/CCR5). Cells were counted 
by using FlowCount Beads (Beckman Coulter). Cytometric analysis was 
performed with FACSCalibur using CellQuest (BD Biosciences) and FCS 
Express (De Novo) software. Cells were separated by fl  uorescence-activated 
cell sorting (FACSAria and FACSDiva; BD Biosciences). 
and chemokine receptors, and attenuates cytokine recep-
tor signaling by up-regulating SOCS-1 and -2, the IL-1 decoy 
receptor, and by down-regulating Jak2, the kinase involved 
in IL-12 signaling.   Twist1   in Th1 cells thus acts as an endog-
enous regulator limiting the proinfl   ammatory potential of 
Th1 cells in the continuous presence of antigen, i.e., repeated 
activation of NFAT and NF-    B. 
  The key role of   twist1   expression by Th1 cells for the self-
limitation of Th1-induced infl  ammation is evident from the 
present analysis of murine models of infl  ammation. Ectopic 
overexpression of   twist1   in 6-d-old Th1 cells, which still 
had a low endogenous expression level, drastically reduced 
their pathogenic contribution to DTH. Conversely, shRNA-
mediated knockdown of   twist1   in Th1 cells signifi  cantly en-
hanced their potential to induce chronic infl  ammation in 
a murine model of antigen-induced arthritis. In this model, 
OVA-specifi  c Th1 cells, when adoptively transferred into 
SCID mice and challenged by intraarticular OVA, induce a 
chronic infl  ammation of the joint. Adoptive transfer of Th1 
cells versus Th1 cells with a shRNA-mediated knockdown 
of   twist1   expression demonstrates the relevance of   twist1   ex-
pression by Th1 cells for the control of immunopathology. 
When analyzed on day 21 after transfer, mice with a knock-
down of   twist1   expression in Th1 cells showed increased hy-
perplasia of the lining cells and synovial fi  broblasts in the 
sublining layer, pannus formation, and vascularization. Num-
bers of Gr-1  +   granulocytes and F4/80  +   macrophages, as well 
as TNF-     expression of lining and sublining cells, were in-
creased in the Th1   twist1   knockdown situation. 
  Why is expression of   twist1   up-regulated gradually? One 
explanation might be that a regulatory gene is not expressed in 
initial Th1 activations, to allow full initial reactivity of the Th1 
cells. Accordingly, ectopic   twist1   expression in Th1 cells right 
from the beginning impairs their function in acute infl  amma-
tion of DTH. In repeated restimulations, refl  ecting a lack of 
clearance of the antigen and increased risk of immunopathol-
ogy, regulation of Th1 may help to limit immunopathology, 
as we show in the chronic infl  ammation of the antigen-
induced arthritis model by knockdown of   twist1  , but   twist1  -
expressing Th1 cells are still capable of driving infl  ammation. 
  Apart from its role in limiting immunopathology in chronic 
infl  ammation,   twist1   and the genes controlled by it could be 
regarded as biomarkers for pathogenic EM cells.   Twist1   is not 
imprinted for enhanced expression in naive and CM CCR7  +   
Th cells. Even CCR7       CCR5  +   Th1 EM cells will only ex-
press a low level of   twist1   upon restimulation compared with 
Th cells from chronically infl  amed tissue. Initial clinical stud-
ies aiming at a complete depletion of CD4  +   T lymphocytes 
in patients with chronic infl  ammatory diseases suggested a 
clinical benefi  t, but the studies had to be terminated because 
of the severe side eff  ects of systemic depletion of Th lympho-
cytes (  35  –  37  ). Targeting of CD4- and CD3-expressing cells 
with nondepleting antibodies and neutralization of Th-re-
lated eff  ector cytokines have demonstrated clinical effi   cacy 
(  12, 13, 15, 38  –  40  ), but all of them impair protective as well 
as pathogenic T cell memory. Targeting of   twist1  -expressing JEM VOL. 205, August 4, 2008 
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or F4/80 (eBioscience). For detection biotinylated donkey anti  –  rat or donkey 
anti  –  goat (Dianova) secondary antibodies were used followed by the streptav-
idin AP kit (K5005; Dako). Or sections were incubated with goat anti-TNF-     
antibody followed by Alexa Fluor 555-conjugated anti  –  goat antibody (Invit-
rogen) and incubated with rabbit polyclonal anti-CD3 followed by Alexa 
Fluor 488  –  conjugated anti  –  rabbit antibody (Invitrogen). Nuclei were coun-
terstained with DAPI (Roche), and slides were mounted in Fluoromount-G 
(SouthernBiotech). Images were acquired using a fl  uorescence microscope 
(AxioImager Z1) equipped with a charge-coupled device camera (AxioCam 
MRm) and processed with Axiovision software (Carl Zeiss, Inc.). 
  Immunoblot.     Immunoblot was performed with a monoclonal Twist-spe-
cifi   c antibody (    TwiMab-1) (  45  ) conjugated in-house to digoxygenin 
(Roche Diagnostics), anti  –  tubulin-     (DM1A; Calbiochem), anti-T-bet 
(4B10; Santa Cruz Biotechnology, Inc.), or anti-I    B     (Cell Signaling Tech-
nology), followed by incubation with horseradish peroxidase  –  coupled anti-
digoxigenin FAB-fragments (Roche) or anti  –  mouse or anti  –  rabbit (Santa 
Cruz Biotechnology, Inc.) secondary antibodies. Individual bands were vi-
sualized with enhanced chemiluminescence (GE Healthcare) and the Intelli-
gent Dark Box System LAS-3000 (Fujifi  lm). 
  Retroviral expression vectors and retroviral infection.     The   twist1  -tar-
geting shRNA vector was generated by amplifi  cation of the EF1    -promotor 
and GFP from pLVTHM, provided by D. Trono (Ecole Polytechnique 
F  é  d  é  rale de Lausanne, Lausanne, Switzerland) followed ligation into pQCXIX 
(Clontech Laboratories, Inc.) with XbaI and EcoRV. The   twist1   target sequence 
corresponds to Twist-siRNA3 (5    -AAGCTGAGCAAGATTCAGACC-3    ), 
as published by Yang et al. (  3  ). A corresponding scrambled sequence was 
used as control. The DNA oligonucleotides were subcloned using HpaI and 
XhoI into pLL3.7, which was provided by L. Van Parijs (Massachusetts 
Institute of Technology, Cambridge, MA). The fragment containing the 
murine U6-promotor and the shRNA-encoding sequence was amplifi  ed by 
PCR, introducing an additional 5    -XhoI site and ligated into the SalI site of 
pQXIX-  gfp   located in the inactivated 3    -LTR. For retroviral overexpression 
the vector GFP-RV (  46  ) was used, provided by K.M. Murphy (Howard 
Hughes Medical Institute, St. Louis, Missouri). Murine   t-bet   (cDNA gener-
ated from Th1-cells), murine   twist1   (IMAGE cDNA clone; AccessionID: 
BC033434-NCBI), and constitutively active I    B    M (pCMV-I    B    M; 
Clontech Laboratories, Inc.) were amplifi  ed, introducing BglII- and XhoI-
compatible restriction sites and ligated into the vector upstream of the inter-
nal ribosome entry site- gfp   cassette. Sequences of primers and oligonucleotides 
for shRNA expression are listed in Table S5. Retroviral stocks were obtained 
by calcium phosphate cotransfection of HEK293 cells with the retrovirus 
packaging plasmids pECO and pCGP. The medium was replaced after 4 h, 
and viral supernatants were collected 24  –  48 h later. Th cells were infected 
40 h after activation by 60 min centrifugation at 700 g at 30  °  C with viral 
  supernatant and 8   μ  g/ml polybrene, followed by replacement of the viral 
  supernatant with the former culture supernatant. 
  Luciferase reporter assay.     NF-    B activity was monitored using the pNF-
    B-Luc vector (Clontech Laboratories, Inc.). Transfection effi   ciency was 
controlled by cotransfecting pRL-TK (Promega). Murine T cells were elec-
troporated with the reporter constructs using Mouse T cell kit (AMAXA) 
and Nucleofector I (AMAXA). Luciferase activity was quantifi  ed with Dual 
Luciferase Assay kit (Promega) and a luminometer (Moonlight 3096; BD 
Biosciences). 
  Microarray experiments.     Total RNA was extracted using Trizol reagent 
(Invitrogen), 10   μ  g was reverse-transcribed, followed by cDNA extraction 
with a PhaseLock gel (Eppendorf), and precipitated with ethanol and ammo-
nium acetate. Biotinylated cRNA was transcribed with the MEGAscript 
high-yield transcription kit (Ambion), fragmented, and the hybridization 
cocktail was prepared according to Aff  ymetrix protocols (15   μ  g fragmented 
biotin-labeled cRNA spiked with Eukaryotic Hybridization control). The 
  Cell culture.     Naive CD4  +  CD62L  +   lymphocytes from 6  –  8-wk-old DO11.10 
mice were isolated and polarized under Th1 or Th2 conditions, as previously 
described (  15  ). Irradiated (30 Gy) BALB/c splenocytes were used as APCs at 
a ratio of 5:1 and the cognate peptide OVA  323-339   (provided by R. Volkmer-
Engert, Humboldt University of Berlin, Berlin, Germany) was added at 0.5   μ  M. 
Alternatively, plates were coated with 3   μ  g/ml anti-CD3 (145-2C11) in 
PBS, and CD4  +   cells were plated at a density of 2   ×   10  6   cells/ml in medium 
plus 1   μ  g/ml soluble anti-CD28 (37.51). For Th17 diff  erentiation, cells were 
stimulated in the presence of 1 ng/ml TGF-     (R  &  D Systems), 20 ng/ml 
IL-6 (R  &  D Systems), and 20 ng/ml IL-23 (R  &  D Systems), as well as 10   μ  g/ml 
anti-IL-4 and 10   μ  g/ml anti  –  IFN-    . Irradiated IL-12 p35      /      splenocytes 
were used as APCs. Every 6 d, viable Th cells were harvested and restimu-
lated under the original conditions, except that 10 ng/ml murine IL-2 (R  &  D 
Systems) was added to the Th1 and Th2 cultures. 
  Mitogenic restimulation and intracellular cytokine staining.     Cells 
were restimulated with 10 ng/ml PMA, and 1   μ  g/ml ionomycin or with 
plate-bound anti-CD3 (10   μ  g/ml), and soluble anti-CD28 (1   μ  g/ml). For 
restimulation of murine T cells, 10 ng/ml IL-2 was added. For intracellular 
staining of cytokines, T cells were stimulated for 2 h with PMA/ionomycin 
and an additional 3 h with 5   μ  g/ml of brefeldin A. Cells were fi  xed with 2% 
formaldehyde in PBS for 15 min at room temperature and permeabilized 
with 0.5% wt/vol saponin. 
  ChIP.     ChIP was performed as previously described (  15  ) using anti-NFAT1 
(AB1-209; ImmunoGlobe Antikoerpertechnik), anti-p65 (C-20; Santa Cruz 
Biotechnology, Inc.), anti-STAT4 (C-20; Santa Cruz Biotechnology, Inc.), 
anti  –  acetyl-histone 3 (#06  –  599; Millipore) or anti  –  trimethyl-K4-histone 3 
(#07  –  473; Millipore), followed by incubation with Protein A micro-
beads. The relative amount of precipitated DNA was calculated with 
E    Δ  Cp     (input - immunoprecipitate)  . The following primers were used to amplify the proxi-
mal  twist1   promoter: (   150 forward) 5   -GGGCTGGAAAGAGGAAACTT-
3    ; (+4 reverse) 5    -CGCGAGGTGTCTGAGAGTT-3    . 
  Th1-mediated DTH model.     The OVA-specifi  c DTH model was per-
formed as described elsewhere (  43  ). In brief, 5   ×   10  5   Th1 cells were injected 
i.v. into BALB/c mice, and 24 h later, the DTH response was induced by 
s.c. injection of 250 ng OVA  323-339  /IFA into the left footpad. PBS/IFA, in-
jected into the right footpad, served as a control. The footpad thickness 
measured before the injection of the antigen was subtracted from the footpad 
thickness measured during the DTH response. The homing of adoptively 
transferred Th1 cells was performed as previously described (  44  ). In brief, Th 
cells were labeled with   51  Chromium (Amersham Buchler) at 37  °  C (2   ×   10  7   
cells/ml; 20   μ  Ci/ml) in fresh medium. Removal of dead cells was done by 
gradient centrifugation (17.1% isotonic Nycodenz). Labeled cells were co-
adoptively transferred into recipient animals at 1 d after the DTH induction. 
24 h later, indicated tissues were removed and diff  erential measurement of 
recovered radioactivity was done on a      counter (Wallac Counter). 
  Antigen-induced arthritis.     2   ×   10  6   12-d-old GFP  +   Th1 cells were trans-
ferred i.v. into naive SCID mice. 1 d later, arthritis was induced by intraar-
ticular injection of 60   μ  g cationized OVA into one knee joint. The 
contralateral knee joint was left untreated. 21 d later, mice were killed and 
knee joints were fi  xed in 10% formaldehyde, decalcifi  ed in saturated EDTA 
solution, and embedded in paraffi   n. Knee joint sections were stained with 
hematoxylin/eosin and scored for exudates, granulocyte infi  ltration, hyper-
plasia, fi   broblast proliferation/mononuclear cell infi  ltration,  periarticular 
mononuclear cell infi  ltration (each scoring 0  –  3), bone/cartilage destruction 
(scoring 0  –  4), and an additional score of 1 for visible fi  brin deposition and 
periarticular granulocyte infi  ltration, resulting in a maximum score of 21. 
  Immunohistochemistry.     Formalin-fi  xed  paraffi   n-embedded  tissue  was 
subjected to a heat-induced epitope retrieval step and stained with anti-CD3 
(#N1580; Dako), TNF-     (PeproTech), anti-Gr-1 (RB6-8C5; eBioscience), 1900 TWIST1 CONTROLS TH1-MEDIATED IMMUNITY   | Niesner et al. 
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